Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ranitidine-induced cranial dystonia

B J Davis1, E A Aul, M A Granner

  • 1Department of Neurology, University of Iowa College of Medicine, Iowa City, USA.

Clinical Neuropharmacology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantification of Blood Velocity with 4D Digital Subtraction Angiography Using the Shifted Least-Squares Method.

AJNR. American journal of neuroradiology·2018
Same author

Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray.

Brachytherapy·2016
Same author

Thalamic ependymoma presenting as recurrent subarachnoid hemorrhage.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.

Autonomic & autacoid pharmacology·2015
Same author

Risk for transmission of Naegleria fowleri from solid organ transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Polychlorinated dibenzo-p-dioxins (PCDDs) and furans (PCDFs) in urban air and deposition in the United Kingdom.

Environmental science and pollution research international·2013
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Ranitidine, a histamine H2 antagonist, can cause cranial dystonia. This drug-induced movement disorder resolved upon ranitidine discontinuation and reappeared with re-administration, suggesting a causal link.

Area of Science:

  • Neurology
  • Pharmacology
  • Movement Disorders

Background:

  • Histamine H2 receptor antagonists are widely used for acid suppression.
  • Adverse neurological effects, including abnormal involuntary movements, have been rarely reported with this drug class.

Observation:

  • A patient developed cranial dystonia shortly after initiating ranitidine therapy.
  • The dystonic symptoms resolved upon discontinuation of ranitidine.
  • Recurrence of symptoms was observed upon re-challenge with ranitidine.

Findings:

  • This case represents the second report of ranitidine-induced abnormal involuntary movements.
  • It is the first documented instance of ranitidine causing dystonia.
  • The exact mechanism remains unclear, but a central cholinergic effect is hypothesized.

Related Experiment Videos

Implications:

  • Clinicians should be aware of the potential for ranitidine to induce dystonia.
  • Cranial dystonia may be a rare adverse effect of ranitidine.
  • Further research into the neuropharmacological effects of ranitidine is warranted.